2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year.

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000423 002737 300111 300170 300713 Beijing Tongrentang Dong-E-E-Jiao Hand Enterprise Solutions Harbin Pharmaceutical Group Shenzhenrease Technology Sunflower Pharmaceutical Group Tianjin Zhongxin Pharmaceutical Group Corporation Zhangzhou Pientzehuang Pharmaceutical Zhejiang Sunflower Great Health Limited Liability Company Regulations Earnings Human Resources Management Strategy, Marketing Annual, Special Corporate Meeting Annual Report Board Of Directors Patent, Copyright, Trademark Research, Development Health, Beauty Product Pharmaceutical Energy, Resource Financial, Business Service Insurance Manufacturing, Engineering Prices Market, Exchange Securities Diseases, Conditions Medicine Series Cosmetics Economy, Business, Finance Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » 2021 Earnings Season Pien Tze Huang: The cost of drugs for liver diseases, the mainstay of revenue, has grown, and the gross profit has declined slightly. The core strategy is adjusted by changing the chairman twice a year.